Doxorubicin Hydrochloride and Alvocidib in Treating Patients With Metastatic or Recurrent Sarcoma That Cannot Be Removed By Surgery
Clinical trial NCT00098579 · COMPLETED
Trial details
- NCT number
- NCT00098579
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-10-01
- Primary completion
- 2011-07-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.